chemoradiotherapy

Documents about chemoradiotherapy

• Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.#881713ClinicalTrials.gov
• Vestibular Function After Chemoradiotherapy for Nasopharyngeal Carcinoma#902841ClinicalTrials.gov
• Chemoradiotherapy Following Immunotherapy Plus Chemotherapy for Locally-advanced Esophageal Squamous Cell Cancer (RICE)#1032763ClinicalTrials.gov
• Surgery Plus Target-reduction Chemoradiotherapy vs Regular Chemoradiotherapy for Newly Diagnosed Resectable Nasopharyngeal Carcinoma#1102430ClinicalTrials.gov
• Analysis of Nutrition During Chemoradiotherapy in Patients With Gastrointestinal Cancer#1140429ClinicalTrials.gov
• Adjuvant Chemoradiotherapy Versus Chemotherapy for Pancreatic Cancer (ADJUPANC)#1422054ClinicalTrials.gov
• Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer#184849ClinicalTrials.gov
• Endostar Combined With Concurrent Chemoradiotherapy For Locally Advanced Cervical Carcinoma#916676ClinicalTrials.gov
• Camrelizumab Plus Neoadjuvant Chemotherapy or Chemoradiotherapy Versus Chemoradiotherapy in Resectable ESCC.#981186ClinicalTrials.gov
• Combination of Almonertinib and Concurrent Chemoradiotherapy in Unresectable Stage III NSCLC#1047866ClinicalTrials.gov
• Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal Cancer#896867ClinicalTrials.gov
• Induction Chemotherapy Followed by IMRT or Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma#838862ClinicalTrials.gov
• Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma#217028ClinicalTrials.gov
• Enriched-CRT 2017: Advanced Gastric Cancer With LN+ and LVI+, Chemotherapy vs. Chemoradiotherapy#890898ClinicalTrials.gov
• Hypofractionated Chemoradiotherapy for Cervical Cancer#897302ClinicalTrials.gov
• Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase#908441ClinicalTrials.gov
• Ensartinib After Chemoradiotherapy in Stage III ALK-Mutated NSCLC#1439017ClinicalTrials.gov
• Neoadjuvant Versus Adjuvant Therapy in Treating Resectable Thoracic Esophageal Cancer#1451758ClinicalTrials.gov
• Neoadjuvant Chemo-immunotherapy Followed by Concurrent Chemoradiotherapy and Immunotherapy in LACC#1452402ClinicalTrials.gov
• Hypofractionated vs. Conventional Chemoradiotherapy After Induction Chemo-immunotherapy for Unresectable Esophageal Squamous Cell Carcinoma#1395956ClinicalTrials.gov
• Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma#836192ClinicalTrials.gov
• Early Nutritional Intervention in NPC Patients Undergoing Concurrent Chemoradiotherapy#898805ClinicalTrials.gov
• Oral Probiotics on Radiation Enteritis Stage Ⅱ Induced by Pelvic Concurrent Chemoradiotherapy#1308790ClinicalTrials.gov
• Immunotherapy Combined With Chemoradiotherapy for First-line Treatment of Esophageal Squamous Cell Carcinoma（ChinECR）#802422ClinicalTrials.gov
• Cetuximab/Paclitaxel/Cisplatin Concurrent Chemoradiotherapy Followed by Esophagectomy for Loco-regional Esophageal Cancer#802689ClinicalTrials.gov
• Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma#970011ClinicalTrials.gov
• Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma#1161771ClinicalTrials.gov
• Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer#1422205ClinicalTrials.gov
• Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy#1476689ClinicalTrials.gov
• Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients#801394ClinicalTrials.gov
• Hypofractionated Whole Pelvic Chemoradiotherapy With iRex Optimization in Cervical Cancer#806461ClinicalTrials.gov
• Perioperative Chemoradiotherapy for Potentially Resectable Gastric Cancer#830131ClinicalTrials.gov
• Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer#834513ClinicalTrials.gov
• Phase II Trial of Thalidomide Combined With Concurrent Chemoradiotherapy in Esophageal Cancer#893410ClinicalTrials.gov
• Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer#1186196ClinicalTrials.gov
• Concurrent Chemoradiotherapy After Endoscopic Resection for Stage I Esophageal Carcinoma#1212875ClinicalTrials.gov
• A Study of Adebrelimab Combined With Chemoradiotherapy in the Treatment of Esophageal Small Cell Carcinoma#839825ClinicalTrials.gov
• Induction Chemoimmunotherapy Combined With Chemoradiotherapy in Esophageal Cancer#858739ClinicalTrials.gov
• Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer#1030700ClinicalTrials.gov
• The Predictive Value of Cytokines on Response to Preoperative Chemoradiotherapy in Patients With Rectal Cancer#1163188ClinicalTrials.gov
• Retlirafusp Alfa Combined With Chemoradiotherapy in Unresectable ESCC#1462812ClinicalTrials.gov
• PD-1 Antibody Plus Chemoradiotherapy for IB2-IIIB Cervical Cancer#121352ClinicalTrials.gov
• Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer#448273ClinicalTrials.gov
• Lipotecan Based Concurrent Chemoradiotherapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis#847205ClinicalTrials.gov
• Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma#886438ClinicalTrials.gov
• A Phase II Study of Postoperative S-1-Based Chemoradiotherapy in Gastric Cancer#903836ClinicalTrials.gov
• Concurrent Chemoradiotherapy With Weekly Cisplatin Versus Concurrent Chemoradiotherapy With Weekly Cisplatin and Paclitaxel in Locally Advanced Carcinoma Cervix#1164270ClinicalTrials.gov
• Postoperative Sequence Chemoradiotherapy Compared With Chemotherapy Alone for Advanced Gastric Cancer#1262409ClinicalTrials.gov
• The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma#1464627ClinicalTrials.gov
• A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk#842536ClinicalTrials.gov